PARASAL SODIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Parasal Sodium, and when can generic versions of Parasal Sodium launch?
Parasal Sodium is a drug marketed by Panray and is included in one NDA.
The generic ingredient in PARASAL SODIUM is aminosalicylate sodium. There are three drug master file entries for this compound. Additional details are available on the aminosalicylate sodium profile page.
Summary for PARASAL SODIUM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 92 |
Patent Applications: | 6 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PARASAL SODIUM at DailyMed |
US Patents and Regulatory Information for PARASAL SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Panray | PARASAL SODIUM | aminosalicylate sodium | TABLET;ORAL | 006811-011 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Panray | PARASAL SODIUM | aminosalicylate sodium | TABLET;ORAL | 006811-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |